Business
Expanding Steriwave Use Across Vancouver Island
Ondine Biomedical Inc. announced that Cowichan District Hospital, part of Island Health, will adopt its Steriwave nasal photodisinfection technology for orthopedic patients, aiming to prevent surgical site infections. This adoption coincides with the hospital's significant CAD$1.4 billion expansion, which will nearly double its operating rooms to seven, positioning it as a hub for complex orthopedic surgeries. Steriwave, a five-minute light-activated process, eliminates nasal pathogens without contributing to antibiotic resistance, a critical safeguard for a facility increasing its surgical capacity. This move by Cowichan Hospital, which is also expanding its emergency department and becoming a fully electric facility, highlights a commitment to advanced patient safety and infection prevention. Disclaimer*
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n27 January 2026 \n \nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\n \nExpanding Steriwave Use Across Vancouver Island\nIsland Health's New Regional Powerhouse, Cowichan District Hospital, Adopts Steriwave to Lead Vancouver Island in Surgical Innovation\nOndine Biomedical Inc. (AIM: OBI) today announced that Cowichan District Hospital, a facility within the Island Health Authority in British Columbia, is adopting Steriwave® nasal photodisinfection as a standard component of pre-surgical protocols for its orthopedic patients to protect them from the growing risk of multidrug resistance.\nThe adoption of this cutting-edge technology comes as Cowichan Hospital undergoes a massive transformation and prepares for the historic opening of its new CAD$1.4 billion, 607,000-square-foot campus-three times the size of its current facility. The expansion nearly doubles the number of operating rooms, from four to seven, signaling Cowichan's emergence as a premier destination for complex orthopedic surgeries and joint replacements.\nBy integrating Ondine Biomedical's Steriwave system, Cowichan Hospital is providing its orthopedic patients with a \"gold standard\" of infection prevention. Steriwave uses a non-invasive, five-minute light-activated process to eliminate pathogens in the nose-a primary reservoir for bacteria that cause surgical site infections (SSIs). Unlike traditional antibiotics, Steriwave is effective immediately and does not contribute to the \"superbug\" crisis. For a hospital rapidly scaling surgical capacity to meet the needs of a growing population, this innovation is a critical safeguard. Adopters of the technology, such as the Mid Yorkshire Teaching NHS Trust in the UK, have seen hip and knee SSIs plummet by as much as 71%.\nA Future-Forward Medical Hub\nCarolyn Cross, CEO of Ondine Biomedical Inc., commented:\n\"Cowichan is migrating from community hospital to a regional leader in innovation and we are proud to be part of that evolution. As this facility triples in size to become one of the most significant medical centers in British Columbia, the clinical team is ensuring that patient safety keeps pace with that growth. We are honored to support the Cowichan Valley in helping to protect patients and families from the growing threat of drug-resistant infections with ou...